A Case of a Patient With -Associated Myopathy Presenting With a Chief Complaint of Hand Tremor

Overview

Journal Tremor Other Hyperkinet Mov (N Y)

Publisher Ubiquity Press

Date 2024 Oct 7

PMID 39372444

Authors

Xinxin Liao

Qiuxiang Li

Huan Yang

Qiying Sun

Affiliations

Soon will be listed here.

Abstract

Background: Postural tremor is an uncommon and often overlooked phenotype in skeletal myopathy, which may lead to diagnostic delays.

Case Report: A 21-year-old man presented with adolescent onset postural hand tremor as the initial symptom, followed by mild limb muscle weakness. Neurological examination showed restricted ocular motility without diplopia and myopathic facial appearance. A muscle biopsy showed a decrease in type 2A fibers. Whole-exome sequencing identified two novel compound heterozygous variants in gene (NM_017534.6): c.505+2T>C and c.3565 del C. The diagnosis was further validated via bioinformatics analysis and confirmed through familial co-segregation by Sanger sequencing.

Discussion: This report expands the mutational and phenotypic spectrum of -associated myopathy. We suggest that in the differential diagnosis of tremor, besides common neurogenic causes, myogenic etiology should also be considered.

Highlights: Hand tremor in this case expands the phenotype of MYH2-associated myopathy, enhancing our understanding of tremor origins. It underscores the importance of nuanced clinical assessment and genetic screening in complex tremor disorders.

References

Martinsson T, Oldfors A, Darin N, Berg K, Tajsharghi H, Kyllerman M . Autosomal dominant myopathy: missense mutation (Glu-706 --> Lys) in the myosin heavy chain IIa gene. Proc Natl Acad Sci U S A. 2000; 97(26):14614-9. PMC: 18967. DOI: 10.1073/pnas.250289597. View

Wang L, Geist J, Grogan A, Hu L, Kontrogianni-Konstantopoulos A . Thick Filament Protein Network, Functions, and Disease Association. Compr Physiol. 2018; 8(2):631-709. PMC: 6404781. DOI: 10.1002/cphy.c170023. View

Ruppel K, Spudich J . Structure-function analysis of the motor domain of myosin. Annu Rev Cell Dev Biol. 1996; 12:543-73. DOI: 10.1146/annurev.cellbio.12.1.543. View

Telese R, Pagliarani S, Lerario A, Ciscato P, Fagiolari G, Cassandrini D . MYH2 myopathy, a new case expands the clinical and pathological spectrum of the recessive form. Mol Genet Genomic Med. 2020; 8(9):e1320. PMC: 7507101. DOI: 10.1002/mgg3.1320. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Schaefer J, Saak A, Bonnemann C, Jackson S . Myogenic tremor - a novel tremor entity. Curr Opin Neurol. 2021; 34(5):706-713. DOI: 10.1097/WCO.0000000000000976. View

Darin N, Kyllerman M, Wahlstrom J, Martinsson T, Oldfors A . Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles. Ann Neurol. 1998; 44(2):242-8. DOI: 10.1002/ana.410440215. View

Schubach M, Maass T, Nazaretyan L, Roner S, Kircher M . CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions. Nucleic Acids Res. 2024; 52(D1):D1143-D1154. PMC: 10767851. DOI: 10.1093/nar/gkad989. View

Cassini T, Malicdan M, Macnamara E, Lehky T, Horkayne-Szakaly I, Huang Y . MYH2-associated myopathy caused by a novel splice-site variant. Neuromuscul Disord. 2023; 33(3):257-262. PMC: 10023425. DOI: 10.1016/j.nmd.2022.12.014. View

10.

Geist Hauserman J, Stavusis J, Joca H, Robinett J, Hanft L, Vandermeulen J . Sarcomeric deficits underlie MYBPC1-associated myopathy with myogenic tremor. JCI Insight. 2021; 6(19). PMC: 8525646. DOI: 10.1172/jci.insight.147612. View

11.

Tajsharghi H, Darin N, Rekabdar E, Kyllerman M, Wahlstrom J, Martinsson T . Mutations and sequence variation in the human myosin heavy chain IIa gene (MYH2). Eur J Hum Genet. 2005; 13(5):617-22. DOI: 10.1038/sj.ejhg.5201375. View

12.

Tajsharghi H, Hammans S, Lindberg C, Lossos A, Clarke N, Mazanti I . Recessive myosin myopathy with external ophthalmoplegia associated with MYH2 mutations. Eur J Hum Genet. 2013; 22(6):801-8. PMC: 4023224. DOI: 10.1038/ejhg.2013.250. View

13.

Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae J, Fazel Darbandi S, Knowles D, Li Y . Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019; 176(3):535-548.e24. DOI: 10.1016/j.cell.2018.12.015. View

14.

Maniyar A, Singh R, Ojha P, Chaudhary G, Mahto A, Shah A . Myosin Myopathy Presenting as Chronic Progressive External Ophthalmoplegia. Ann Indian Acad Neurol. 2024; 26(6):1024-1025. PMC: 10789400. DOI: 10.4103/aian.aian_552_23. View

15.

Lossos A, Oldfors A, Fellig Y, Meiner V, Argov Z, Tajsharghi H . MYH2 mutation in recessive myopathy with external ophthalmoplegia linked to chromosome 17p13.1-p12. Brain. 2013; 136(Pt 7):e238. DOI: 10.1093/brain/aws365. View

16.

Tajsharghi H, Hilton-Jones D, Raheem O, Saukkonen A, Oldfors A, Udd B . Human disease caused by loss of fast IIa myosin heavy chain due to recessive MYH2 mutations. Brain. 2010; 133(Pt 5):1451-9. DOI: 10.1093/brain/awq083. View

17.

Walker L, de la Hoya M, Wiggins G, Lindy A, Vincent L, Parsons M . Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup. Am J Hum Genet. 2023; 110(7):1046-1067. PMC: 10357475. DOI: 10.1016/j.ajhg.2023.06.002. View